Browse by Section 100 Item List

Highly Specialised Drugs Program (Public Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in public hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies and some of these prescriptions can be dispensed by a community pharmacy. A patient may be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the PBS. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs 		Max qty
units 		No. of
repeats
MP 13725J ABATACEPTabatacept 250 mg injection, 1 vial 3 3 5
MP 5605B ABATACEPTabatacept 250 mg injection, 1 vial 1 1 0
MP 14235F ADALIMUMABadalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes 1 2 0
MP 14286X ADALIMUMABadalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes 1 2 5
MP 12355G ADALIMUMABadalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices 1 2 5
MP 9663N ADALIMUMABadalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices 1 2 0
MP 12348X ADALIMUMABadalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes 1 2 5
MP 9662M ADALIMUMABadalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes 1 2 0
MP 12431G ADALIMUMABadalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes 1 2 0
MP 13228F ADALIMUMABadalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes 1 2 5
MP 12444Y ADALIMUMABadalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices 1 2 0
MP 13212J ADALIMUMABadalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices 1 2 5
MP 12406Y ADALIMUMABadalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes 1 2 0
MP 13293P ADALIMUMABadalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes 1 2 5
MP 12417M ADALIMUMABadalimumab 20 mg/0.4 mL injection, 0.4 mL syringe 2 2 5
MP 12435L ADALIMUMABadalimumab 20 mg/0.4 mL injection, 0.4 mL syringe 2 2 0
MP 10228H ALEMTUZUMABalemtuzumab 12 mg/1.2 mL injection, 1.2 mL vial 5 5 0
MP 10232M ALEMTUZUMABalemtuzumab 12 mg/1.2 mL injection, 1.2 mL vial 3 3 0
MP 12186J AMBRISENTANambrisentan 10 mg tablet, 30 1 30 5
MP 5608E AMBRISENTANambrisentan 10 mg tablet, 30 1 30 5
MP 12212R AMBRISENTANambrisentan 5 mg tablet, 30 1 30 5
MP 5607D AMBRISENTANambrisentan 5 mg tablet, 30 1 30 5
MP 10264F ANAKINRAanakinra 100 mg/0.67 mL injection, 28 x 0.67 mL syringes 1 28 5
MP 14195D ANIFROLUMABanifrolumab 300 mg/2 mL injection, 2 mL vial 1 1 5
MP 5610G APOMORPHINEapomorphine hydrochloride hemihydrate 50 mg/5 mL injection, 5 x 5 mL ampoules 36 180 5
MP 10950H APOMORPHINEapomorphine hydrochloride hemihydrate 50 mg/10 mL injection, 5 x 10 mL syringes 36 180 5
MP 11672H APOMORPHINEapomorphine hydrochloride hemihydrate 30 mg/3 mL injection, 5 x 3 mL cartridges 20 100 5
MP 11477C APOMORPHINEapomorphine hydrochloride hemihydrate 30 mg/3 mL injection, 5 x 3 mL pen devices 20 100 5
MP 11093W APOMORPHINEapomorphine hydrochloride hemihydrate 100 mg/20 mL injection, 5 x 20 mL vials 18 90 5
MP 13313Q AVATROMBOPAGavatrombopag 20 mg tablet, 30 1 30 5
MP 12771E AZACITIDINEazacitidine 100 mg injection, 1 vial 14 14 2
MP 13028Q AZACITIDINEazacitidine 100 mg injection, 1 vial 14 14 5
MP 13036D AZACITIDINEazacitidine 100 mg injection, 1 vial 14 14 2
MP 13042K AZACITIDINEazacitidine 100 mg injection, 1 vial 14 14 2
MP 13044M AZACITIDINEazacitidine 100 mg injection, 1 vial 14 14 5
MP 9597D AZACITIDINEazacitidine 100 mg injection, 1 vial 14 14 2
MP 9598E AZACITIDINEazacitidine 100 mg injection, 1 vial 14 14 5
MPNP 5616N AZITHROMYCINazithromycin 600 mg tablet, 8 2 16 5